PPI Intake and Cumulative Incidence of SBP or other Infections.

Impact of PPI intake on A cumulative incidence of SBP among patients without SBP at the first paracentesis and B cumulative incidence of SBP or other infections among patients without SBP or another infection at the first paracentesis.Statistics: The impact of PPI intake on the cumulative incidence of SBP or other infections was analyzed by a competing risk analysis [32] treating death as a competing risk. In addition to PPI intake, age, HCC, history of variceal bleeding, varices and MELD score were considered covariates.Abbreviations: PPI proton pump inhibitor; SBP spontaneous bacterial peritonitis; SHR subdistribution hazard ratio; HCC hepatocellular carcinoma; MELD model for end-stage liver disease.PPI Intake and Cumulative Incidence of SBP or other Infections.